Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse.
1. The sigma(1) (sigma(1)) receptor cDNA was cloned in several animal species. Molecular tools are now available to identify its endogenous effectors, such as neuroactive steroids, and to establish its precise physiological role. In particular, the sigma(1) receptor is involved in memory processes, as observed in pharmacological and pathological rodent models of amnesia. 2. In order to establish the involvement of sigma(1) receptors in memory, a 16-mer oligodeoxynucleotide antisense to the sigma(1) receptor cDNA (aODN), and its mismatched control (mODN) were prepared and centrally administered into the mouse brain. The anti-amnesic effects induced by the selective sigma(1) agonist PRE-084 and the steroid dehydroepiandrosterone (DHEA) sulphate or pregnenolone sulphate were examined in ODN-treated animals. 3. The aODN treatment failed to affect the dissociation constant (K(d)) but significantly decreased the number of sigma(1) sites (B(max)) labelled with [(3)H]-(+)-SKF-10,047 in the hippocampus and cortex. In these structures, the in vivo binding levels were also diminished, according to the dose and number of injections, as compared with control animals injected with saline or mODN. 4. Cannulation and injections failed to affect the open-field behaviour of the animals. However, the anti-amnesic effects of PRE-084 and DHEA sulphate against the dizocilpine-induced impairments were blocked after aODN treatment in the short- and long-term memory tests. The anti-amnesic effects of pregnenolone sulphate remained unchanged. 5. These observations bring a molecular basis to the modulatory role of sigma(1) receptors in memory, and reveal that the anti-amnesic action of neuroactive steroids may not similarly involve an interaction with sigma(1) receptors.
Maurice
T
T
INSERM U. 336, Behavioural Neuropharmacology group, Institut de Biologie, 4, Blvd Henri IV, 34060 Montpellier, France. maurice@medecine.univ-montp1.fr
Phan
V L
VL
Urani
A
A
Guillemain
I
I
D000647:Amnesia / Q000378:metabolism / Q000523:psychology / Q000628:therapy*; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001665:Binding Sites; D015153:Blotting, Western; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D003687:Dehydroepiandrosterone / Q000494:pharmacology*; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D007859:Learning Disabilities / Q000139:chemically induced / Q000188:drug therapy / Q000523:psychology; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D010620:Phenazocine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011284:Pregnenolone / Q000494:pharmacology*; D017480:Receptors, sigma / Q000819:agonists / Q000235:genetics / Q000502:physiology*; D000097605:Sigma-1 Receptor
D003687:Dehydroepiandrosterone; D016291:Dizocilpine Maleate; D009025:Morpholines; D016376:Oligonucleotides, Antisense; D010620:Phenazocine; D011284:Pregnenolone; D017480:Receptors, sigma; D000097605:Sigma-1 Receptor; C018370:pregnenolone sulfate; C071738:2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate; C012134:SK&F 10047